Docetaxel (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Docetaxel drug offered from Actavis Pharma, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Docetaxel |
SUBSTANCE NAME: | DOCETAXEL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-09-01 |
END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Docetaxel from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2014-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45963-734_0414132a-71b4-40e3-bca0-2fbec324a969 |
PRODUCT NDC: | 45963-734 |
APPLICATION NUMBER: | NDA203551 |
Other DOCETAXEL Pharmaceutical Manufacturers / Labelers: